Clinical Research Directory
Browse clinical research sites, groups, and studies.
Aspirin Continuation or Discontinuation in Conservative Treatment for Chronic Subdural Hematoma
Sponsor: Tao Liu
Summary
This clinical study aims to learn about the efficacy and safety of aspirin continuation or discontinuation in conservative treatment for chronic subdural hematoma. All participants received standard conservative treatment for chronic subdural hematoma, with a randomized intervention to either continue or discontinue aspirin administration. By participating in this study, participants can receive additional scientific guidance on aspirin medication management beyond routine conservative treatment, thereby optimizing individualized therapy.
Official title: Safety and Efficacy of Aspirin Continuation or Discontinuation in Conservative Treatment for Chronic Subdural Hematoma: A Randomized Clinical Trial
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
143
Start Date
2025-10-15
Completion Date
2028-12
Last Updated
2025-11-21
Healthy Volunteers
No
Conditions
Interventions
Aspirin Continuation
All participants received standard conservative treatment for chronic subdural hematoma, with a randomized intervention to continue aspirin administration. This group of participants received oral administration of aspirin at a dose of 100 mg per day.
Aspirin Discontinuation
All participants received standard conservative treatment for chronic subdural hematoma, with a randomized intervention to discontinue aspirin administration. This group of participants did not use aspirin during the treatment period.
Locations (2)
Xuanwu Hospital Capital Medical University
Beijing, China
Tianjin Medical University General Hospital
Tianjin, China